In Vitro Diagnostic Test Detects Active Lyme Borreliosis

An in vitro diagnostic test for the detection of active Lyme Borreliosis is offered as a diagnostic service by a clinical diagnostic service laboratory in Germany.

Dubbed SpiroFind, and offered by Boulder Diagnostics (Boulder, CO, USA), the test can detect active Lyme Borreliosis through all stages of disease from early disease to late and persistent manifestation. The test is based on measuring the cellular immune response to a specific challenge with the Borrelia organism. The effectiveness of the SpiroFind test was confirmed in a clinical study at the Radboud University Nijmegen Medical Center, which was submitted for presentation at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) conference in Berlin (Germany) in April 2013.

"We are proud to offer this important new tool for the correct diagnosis of Lyme disease," commented Dr. Wolfgang Pieken, CEO of Boulder Diagnostics Inc., and added, "The SpiroFind test is the first method to query the trained immunity to Borrelia infection as a signal for active disease."

"At our clinical laboratory in Mellrichstadt, Germany, we now accept whole blood samples for testing by the SpiroFind method," stated Dr. Anton Waldherr, laboratory physician of Boulder Diagnostics Europe GmbH.

Related Links:
Boulder Diagnostics